Quality of life has always been the mission of the life science industry. However, under new outcomes-based reimbursement models marketers must migrate the focus from generating high patient volumes to engaging individuals and demonstrating positive clinical results. Under this model, marketers must engage and cultivate an ongoing dialogue with the “whole patient”, helping the brand discern which combinations of products, services, technologies, incentives and support prove most effective in influencing behavioral change.
Enter Signals Analytics, creators of the only cloud-based augmented intelligence and decision science platform that transforms the world’s unconnected data and real world evidence into actionable insights to enhance therapeutic outcomes, optimize product portfolio health and propel patient-centered innovation. By utilizing Signals Intelligence Streams, life sciences marketers can pinpoint disease, analyze experience, optimize messaging and continuously engage patient populations in order to affect the context in which therapies are adopted and maximize value delivered into the healthcare system.
“Signals enables us to understand the real-time patient treatment journey and allows us to build more effective commercialization strategies that closely align with patient needs.”
– VP of Marketing for TA at a Top 5 Pharmaceuticals Company
Signals Analytics Impact to Your Business
Demonstrate Value throughout the Continuum of Care by Aligning with Patient Needs, Desires, and Demands
Move Beyond Disease Awareness and Education by Uncovering and Reshaping Patient and Provider Attitudes & Beliefs
Monitor the Environment, Lifestyle and Behavior of Patient Populations to Assure Effective Outreach and Engagement
Incorporate Patient, Provider, Payor, Regulator, Key Opinion Leader and Public Sentiment in Go to Market Strategies
Discover Omnichannel Patient and Provider Experiences to Renovate Approaches and Value Propositions
One of the World’s Largest Life Sciences Companies
Extends Therapeutic Leadership
A leading global pharmaceutical company required better insight into patient engagement and experiences with its Metabolics portfolio. The precision listening and insight detection capabilities of Signals Playbook revealed that although current communications focused on therapeutic features and benefits, patients actually desired comprehensive disease management content. The company is now deploying Signals Playbook across its global marketing and business development organization to empower them with a platform to monitor unmet patient needs, competitor pipeline strategies and emerging therapeutic solutions.
The Signals Analytics Difference
Precision Intelligence That Matters Most to Your Enterprise
Real Time Signals Detection with Validated Source Data
Built By Industry Experts For Industry Experts
Rapid Business Impact and Value Right Out of the Box
Machine Learning Combined with Human Intelligence
Signals Analytics Headquarters
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
(917) 470 9110
Signals Analytics Labs
7 Giborei Israel St.
P.O.B 8374, Netanya 4250407, Israel
+972 73 718 1650